AstraZeneca has had a setback in its late-stage oncology pipeline, after AKT inhibitor ceralasertib, given in combination with cancer immunotherapy Imfinzi, failed to extend survival in a lung cancer ...
Switch to solar with a system built for you. The ConsumerAffairs Research Team conducted an unbiased evaluation of top solar panel brands on the market. To pick the best, we looked for high efficiency ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results